Control group No. 30 | Patients group No. 60 | p-value | DM only No. 20 | Diabetic nephropathy No. 20 | DM + cardiovascular No. 20 | p-value | ||
---|---|---|---|---|---|---|---|---|
Systolic BP (mmHg) | Mean ± SD | 109.00 ± 9.14 | 128.83 ± 14.39 | < 0.0001 | 125.00 ± 11.47 | 133.00 ± 17.20 | 128.50 ± 13.48 | < 0.0001 |
Diastolic BP (mmHg) | Mean ± SD | 70.00 ± 6.43 | 81.17 ± 8.65 | < 0.0001 | 81.50 ± 6.71 | 82.00 ± 11.96 | 80.00 ± 6.49 | < 0.0001 |
FBG (mg/dl) | Mean ± SD | 86.00 ± 10.98 | 137.20 ± 46.35 | < 0.0001 | 116.95 ± 31.29 | 156.60 ± 39.42 | 138.05 ± 57.54 | < 0.0001 |
2hPP (mg/dl) | Mean ± SD | 122.00 ± 8.73 | 241.52 ± 82.38 | 0.0001 | 202.75 ± 71.12 | 274.10 ± 55.56 | 247.70 ± 100.95 | < 0.0001 |
HbA1C% | Mean ± SD | 5.35 ± 0.14 | 8.15 ± 1.71 | < 0.0001 | 7.43 ± 1.49 | 8.93 ± 1.16 | 8.11 ± 2.08 | < 0.0001 |
Urea (mg /dl) | Mean ± SD | 21.73 ± 4.39 | 39.87 ± 15.04 | < 0.0001 | 28.30 ± 4.62 | 54.30 ± 14.03 | 37.00 ± 10.74 | < 0.0001 |
Creatinine (mg/dl) | Mean ± SD | 0.67 ± 0.10 | 1.04 ± 0.24 | < 0.0001 | 0.95 ± 0.21 | 1.13 ± 0.30 | 1.05 ± 0.17 | < 0.0001 |
A/C (mg) | Median | 7 (4 − 9) | 16 (9.3 − 168) | < 0.0001 | 12.5 (8–19) | 201.5 (168–411) | 11.5 (8–13) | < 0.0001 |
e-GFR (ml/min/1.73 m2) | Mean ± SD | 121.13 ± 17.70 | 73.32 ± 19.06 | < 0.0001 | 81.50 ± 19.64 | 67.50 ± 21.86 | 70.95 ± 12.34 | < 0.0001 |
LDL/cholesterol (mg/dl) | Mean ± SD | 74.87 ± 11.38 | 118.15 ± 32.95 | < 0.0001 | 114.45 ± 20.08 | 115.00 ± 37.79 | 125.00 ± 38.28 | < 0.0001 |
TG (mg/dl) | Mean ± SD | 84.00 ± 29.17 | 122.78 ± 36.33 | < 0.0001 | 129.15 ± 36.70 | 133.50 ± 25.25 | 105.70 ± 40.55 | < 0.0001 |
Total cholesterol (mg/dl) | Mean ± SD | 123.73 ± 40.66 | 185.98 ± 47.38 | < 0.0001 | 173.95 ± 44.73 | 196.30 ± 37.57 | 187.70 ± 57.36 | < 0.0001 |
HDL (mg/dl) | Mean ± SD | 69.6 ± 6.1 | 52.72 ± 11.65 | < 0.0001 | 56.00 ± 11.08 | 48.30 ± 12.34 | 53.85 ± 10.98 | < 0.0001 |